APA (7th ed.) Citation

HS, L., PH, S., SH, H., WC, L., JY, C., MC, M., . . . HK, Y. (2024). Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients-A randomized, open-label, controlled phase II clinical trial. Stem cell research & therapy, 15(1), 443. https://doi.org/10.1186/s13287-024-04021-7

Chicago Style (17th ed.) Citation

HS, Lin, et al. "Long Term Outcomes of Intracarotid Arterial Transfusion of Circulatory-derived Autologous CD34 + cells for Acute Ischemic Stroke Patients-A Randomized, Open-label, Controlled Phase II Clinical Trial." Stem Cell Research & Therapy 15, no. 1 (2024): 443. https://doi.org/10.1186/s13287-024-04021-7.

MLA (9th ed.) Citation

HS, Lin, et al. "Long Term Outcomes of Intracarotid Arterial Transfusion of Circulatory-derived Autologous CD34 + cells for Acute Ischemic Stroke Patients-A Randomized, Open-label, Controlled Phase II Clinical Trial." Stem Cell Research & Therapy, vol. 15, no. 1, 2024, p. 443, https://doi.org/10.1186/s13287-024-04021-7.